AI-generated summary
The authors report a randomized controlled trial in 50 children aged 8 to 12 with myopia, comparing photobiomodulation therapy plus spectacles against spectacles alone over 12 months. The intervention group showed less axial length growth and smaller myopia progression than controls, with no clear differences in other measured parameters. The study is small, and the abstract's conclusion that the therapy is effective is stated by the authors.
- Participants
- 50
- Who or what was studied
- Children aged 8 to 12 years with myopia (spherical equivalent of -0.75 D or worse)
- Limits stated in the abstract
- The abstract reports a small sample with 78% retained at final follow-up, and it does not state the wavelength used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Trial Registration
Chinese Clinical
Trial Registration Number
ChiCTR2100043619. Registered on 23/02/2021; prospectively registered. http://www.chictr.org.cn/showproj.aspx?proj=121302 .
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Myopia, Randomized controlled trial, Photobiomodulation therapy, Trial registration, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.